Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Irradiation in the Production, Processing, and Handling of Food, 27332-27333 [2018-12614]
Download as PDF
27332
Federal Register / Vol. 83, No. 113 / Tuesday, June 12, 2018 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Guidance section
Number of
respondents
FDA form
Number of
responses per
respondent
Average
burden per
response
Total annual
responses
Total hours
Section II; Human Food .....................
Section III; Animal Food ....................
3942a
3942b
37,134
1,120
.5
.5
18,567
560
.5 (30 minutes) ....
.5 (30 minutes) ....
9,284
280
Total ............................................
........................
........................
........................
........................
..............................
9,564
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Consistent with the estimates found
in our Preventive Controls for Human
Food Rule, we estimate that
approximately 37,134 human food
facilities will each spend approximately
30 minutes (0.5 hour) reporting their
status as a qualified facility to FDA
every 2 years. Thus, dividing this figure
by two to determine the annual burden,
we estimate there will be 18,567
responses and 9,284 burden hours
associated with this information
collection element.
Similarly, and consistent with the
estimates found in our Preventive
Controls for Animal Food Rule, we
estimate that approximately 1,120
animal food facilities will each spend
approximately 30 minutes (0.5 hour)
reporting their status as a qualified
facility to FDA every 2 years. Thus,
dividing this figure by two to determine
the annual burden, we estimate there
will be 560 responses and 280 burden
hours associated with this information
collection element.
The draft guidance also refers to
previously approved collections of
information found in FDA regulations.
The collections of information in 21
CFR part 117 have been approved under
OMB control number 0910–0751. The
collections of information in 21 CFR
part 507 have been approved under
OMB control number 0910–0789.
Dated: June 7, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018–12615 Filed 6–11–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Irradiation in the Production,
Processing, and Handling of Food
Food and Drug Administration
OMB Control Number 0910–0186—
Extension
[Docket No. FDA–2018–N–0073]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Irradiation in the
Production, Processing, and Handling
of Food
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or we) is
announcing that a proposed collection
of information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
SUMMARY:
Fax written comments on the
collection of information by July 12,
2018.
DATES:
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, Fax: 202–
395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0186. Also
include the FDA docket number found
in brackets in the heading of this
document.
ADDRESSES:
Ila
Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
sradovich on DSK3GMQ082PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
16:21 Jun 11, 2018
Jkt 244001
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
This information collection supports
FDA regulations. Specifically, under
sections 201(s) and 409 of the Federal
Food, Drug, and Cosmetic Act (FD&C
Act) (21 U.S.C. 321(s) and 348), food
irradiation is subject to regulation under
the food additive premarket approval
provisions of the FD&C Act. The
regulations providing for uses of
irradiation in the production,
processing, and handling of food are
found in part 179 (21 CFR part 179). To
ensure safe use of a radiation source,
§ 179.21(b)(1) requires that the label of
sources bear appropriate and accurate
information identifying the source of
radiation and the maximum (or
minimum and maximum) energy of the
emitted radiation. Section 179.21(b)(2)
requires that the label or accompanying
labeling bear adequate directions for
installation and use and a statement
supplied by FDA that indicates
maximum dose of radiation allowed.
Section 179.26(c) requires that the label
or accompanying labeling bear a logo
and a radiation disclosure statement.
Section 179.25(e) requires that food
processors who treat food with radiation
make and retain, for 1 year past the
expected shelf life of the products up to
a maximum of 3 years, specified records
relating to the irradiation process (e.g.,
the food treated, lot identification,
scheduled process, etc.). The records
required by § 179.25(e) are used by FDA
inspectors to assess compliance with the
regulation that establishes limits within
which radiation may be safely used to
treat food. We cannot ensure safe use
without a method to assess compliance
with the dose limits, and there are no
practicable methods for analyzing most
foods to determine whether they have
been treated with ionizing radiation and
are within the limitations set forth in
part 179. Records inspection is the only
way to determine whether firms are
complying with the regulations for
treatment of foods with ionizing
radiation.
E:\FR\FM\12JNN1.SGM
12JNN1
27333
Federal Register / Vol. 83, No. 113 / Tuesday, June 12, 2018 / Notices
In the Federal Register of January 26,
2018, (83 FR 3734), FDA published a 60day notice requesting public comment
on the proposed collection of
information. No comments were
received.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Number of
recordkeepers
21 CFR section
Number of
records per
recordkeeper
Total annual
records
Average
burden per
recordkeeping
Total hours
179.25(e); records for large processors ..............................
179.25(e); records for small processors ..............................
4
4
300
30
1,200
120
1
1
1,200
120
Total ..............................................................................
........................
........................
........................
........................
1,320
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Upon review of the information
collection we have retained the
currently approved burden estimate.
FDA’s estimate of the recordkeeping
burden under § 179.25(e) is based on
experience regulating the safe use of
radiation as a direct food additive. The
number of firms who process food using
irradiation is extremely limited. We
estimate that there are four irradiation
plants whose business is devoted
primarily (i.e., approximately 100
percent) to irradiation of food and other
agricultural products. Four other firms
also irradiate small quantities of food.
We estimate that this irradiation
accounts for no more than 10 percent of
the business for each of these firms.
Therefore, the average estimated burden
is based on four facilities devoting 100
percent of their business to food
irradiation (4 × 300 hours = 1,200 hours
for recordkeeping annually), and four
facilities devoting 10 percent of their
business to food irradiation (4 × 30
hours = 120 hours for recordkeeping
annually). No burden has been
estimated for the labeling requirements
in §§ 179.21(b)(1), 179.21(b)(2), and
179.26(c) because the disclosures are
supplied by FDA. Under 5 CFR
1320.3(c)(2), the public disclosure of
information originally supplied by the
Federal Government to the recipient for
the purpose of disclosure to the public
is not subject to review by the OMB
under the Paperwork Reduction Act of
1995.
Dated: June 7, 2018.
Leslie Kux,
Associate Commissioner for Policy.
sradovich on DSK3GMQ082PROD with NOTICES
[FR Doc. 2018–12614 Filed 6–11–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2005–D–0155]
General Principles for Evaluating the
Human Food Safety of New Animal
Drugs Used in Food-Producing
Animals; Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a final
guidance for industry (GFI) #3 entitled
‘‘General Principles for Evaluating the
Human Food Safety of New Animal
Drugs Used in Food-Producing
Animals.’’ This guidance describes the
type of information that the FDA’s
Center for Veterinary Medicine (CVM)
recommends sponsors provide to
address the human food safety of new
animal drugs used in food-producing
animals. The human food safety
evaluation of new animal drugs used in
food-producing animals helps ensure
that food derived from treated animals
is safe for human consumption. CVM
developed this guidance to inform
sponsors of the scientific data and/or
information that may provide an
acceptable basis to determine that the
residue of a new animal drug in or on
food, when consumed, presents a
reasonable certainty of no harm to
humans.
DATES: The announcement of the
guidance is published in the Federal
Register on June 12, 2018.
ADDRESSES: You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
VerDate Sep<11>2014
16:21 Jun 11, 2018
Jkt 244001
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2005–D–0155 for ‘‘General Principles
for Evaluating the Human Food Safety
of New Animal Drugs Used in FoodProducing Animals.’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
E:\FR\FM\12JNN1.SGM
12JNN1
Agencies
[Federal Register Volume 83, Number 113 (Tuesday, June 12, 2018)]
[Notices]
[Pages 27332-27333]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12614]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2018-N-0073]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Irradiation in the
Production, Processing, and Handling of Food
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing
that a proposed collection of information has been submitted to the
Office of Management and Budget (OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by July
12, 2018.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
Fax: 202-395-7285, or emailed to [email protected]. All
comments should be identified with the OMB control number 0910-0186.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: Ila Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
[email protected].
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Irradiation in the Production, Processing, and Handling of Food
OMB Control Number 0910-0186--Extension
This information collection supports FDA regulations. Specifically,
under sections 201(s) and 409 of the Federal Food, Drug, and Cosmetic
Act (FD&C Act) (21 U.S.C. 321(s) and 348), food irradiation is subject
to regulation under the food additive premarket approval provisions of
the FD&C Act. The regulations providing for uses of irradiation in the
production, processing, and handling of food are found in part 179 (21
CFR part 179). To ensure safe use of a radiation source, Sec.
179.21(b)(1) requires that the label of sources bear appropriate and
accurate information identifying the source of radiation and the
maximum (or minimum and maximum) energy of the emitted radiation.
Section 179.21(b)(2) requires that the label or accompanying labeling
bear adequate directions for installation and use and a statement
supplied by FDA that indicates maximum dose of radiation allowed.
Section 179.26(c) requires that the label or accompanying labeling bear
a logo and a radiation disclosure statement. Section 179.25(e) requires
that food processors who treat food with radiation make and retain, for
1 year past the expected shelf life of the products up to a maximum of
3 years, specified records relating to the irradiation process (e.g.,
the food treated, lot identification, scheduled process, etc.). The
records required by Sec. 179.25(e) are used by FDA inspectors to
assess compliance with the regulation that establishes limits within
which radiation may be safely used to treat food. We cannot ensure safe
use without a method to assess compliance with the dose limits, and
there are no practicable methods for analyzing most foods to determine
whether they have been treated with ionizing radiation and are within
the limitations set forth in part 179. Records inspection is the only
way to determine whether firms are complying with the regulations for
treatment of foods with ionizing radiation.
[[Page 27333]]
In the Federal Register of January 26, 2018, (83 FR 3734), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Recordkeeping Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of Average burden
21 CFR section Number of records per Total annual per Total hours
recordkeepers recordkeeper records recordkeeping
----------------------------------------------------------------------------------------------------------------
179.25(e); records for large 4 300 1,200 1 1,200
processors.....................
179.25(e); records for small 4 30 120 1 120
processors.....................
-------------------------------------------------------------------------------
Total....................... .............. .............. .............. .............. 1,320
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
Upon review of the information collection we have retained the
currently approved burden estimate. FDA's estimate of the recordkeeping
burden under Sec. 179.25(e) is based on experience regulating the safe
use of radiation as a direct food additive. The number of firms who
process food using irradiation is extremely limited. We estimate that
there are four irradiation plants whose business is devoted primarily
(i.e., approximately 100 percent) to irradiation of food and other
agricultural products. Four other firms also irradiate small quantities
of food. We estimate that this irradiation accounts for no more than 10
percent of the business for each of these firms. Therefore, the average
estimated burden is based on four facilities devoting 100 percent of
their business to food irradiation (4 x 300 hours = 1,200 hours for
recordkeeping annually), and four facilities devoting 10 percent of
their business to food irradiation (4 x 30 hours = 120 hours for
recordkeeping annually). No burden has been estimated for the labeling
requirements in Sec. Sec. 179.21(b)(1), 179.21(b)(2), and 179.26(c)
because the disclosures are supplied by FDA. Under 5 CFR 1320.3(c)(2),
the public disclosure of information originally supplied by the Federal
Government to the recipient for the purpose of disclosure to the public
is not subject to review by the OMB under the Paperwork Reduction Act
of 1995.
Dated: June 7, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-12614 Filed 6-11-18; 8:45 am]
BILLING CODE 4164-01-P